Polymorphisms of the μ-Opioid Receptor and Dopamine D4 Receptor Genes and Subjective Responses to Alcohol in the Natural Environment

Journal of Abnormal Psychology

Volumn 119, Issue 1, 2010, Pages 115-125

  Ray, Lara A ^a,b   Miranda Jr , Robert ^a   Tidey, Jennifer W ^a   McGeary, John E ^a,c   MacKillop, James ^a,d   Gwaltney, Chad J ^a   Rohsenow, Damaris J ^a,c   Swift, Robert M ^a,c   Monti, Peter M ^a,c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

alcohol; DRD4; EMA; OPRM1; urge to drink

Indexed keywords

ALCOHOL; ASPARTIC ACID; DOPAMINE 4 RECEPTOR; MU OPIATE RECEPTOR; NALTREXONE; PLACEBO;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BEHAVIOR GENETICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; RANDOMIZED CONTROLLED TRIAL; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 77249162223     PISSN: 0021843X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0017550     Document Type: Article

References (58)

1. Anton R.F., Drobes D.J., Voronin K., Durazo-Avizu R., and Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: Temporal effects of drinking. Psychopharmacology 173 (2004) 32-40
2. Anton R.F., Oroszi G., O'Malley S., Couper D., Swift R., Pettinati H., and Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry 65 (2008) 135-144
3. Arias A., Feinn R., and Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug and Alcohol Dependence 83 (2006) 262-268
4. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., and Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine receptor variants. Journal of Neurochemistry 65 (1995) 1157-1165
5. Bergen A.W., Kokaszka J., Peterson R., Long J.C., Virkkunen M., Linnoila M., and Goldman D. Mu opioid receptor gene variants: Lack of association with alcohol dependence. Molecular Psychiatry 2 (1997) 490-494
6. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction. Neurobiology 95 (1998) 9608-9613
7. Brick J. Standardization of alcohol calculations in research. Alcoholism: Clinical and Experimental Research 30 (2006) 1276-1287
8. Dar R., Serlin R.C., and Omer H. Misuse of statistical tests in three decades of psychotherapy research. Journal of Consulting and Clinical Psychology 62 (1994) 75-82
9. Drobes D.J., Anton R.F., Thomas S.E., and Vornin K. Effects of naltrexone and namefene on subjective response to alcohol among non-treatment seeking alcoholics and social drinkers. Alcoholism: Clinical and Experimental Research 28 (2004) 1362-1370
10. Erickson C.K. Review of neurotransmitters and their role in alcoholism treatment. Alcohol and Alcoholism 31 Suppl. 1 (1996) 5-11
11. Filbey F., Ray L.A., Smolen A., Claus E., Audette A., and Hutchison K.E. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcoholism: Clinical and Experimental Research 32 (2008) 1113-1123
12. First M.B., Spitzer R.L., and Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-IV-P, Version 2.0) (1995), Psychiatric Institute, Biometrics Research Department, New York, NY
13. Fisher H.R., Simpson R.I., and Kapur B.M. Calculation of blood alcohol concentration (BAC) by sex, weight, number of drinks and time. Canadian Journal of Public Health 78 (1987) 300-304
14. Flannery B.A., Allen J.P., Pettinati H.M., Rohsenow D.J., Cisler R.A., and Litten R.Z. Using acquired knowledge and new technologies in alcoholism treatment trials. Alcoholism: Clinical and Experimental Research 26 (2002) 423-429
15. Freeman B., Powell J., Ball D., Hill L., Craig I., and Plomin R. DNA by mail: An inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behavior Genetics 27 (1997) 251-257
16. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry 160 (2003) 636-645
17. Grady D.L., Chi H.-C., Ding Y.-C., Smith M., Wang E., Schuck S., et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Molecular Psychiatry 8 (2003) 536-545
18. Greeley J., and Oei T. Alcohol and tension reduction. In: Leonard K.E., and Blane H.T. (Eds). Psychological theories of drinking and alcoholism (1999), Guilford Press, New York, NY 14-53
19. Grobin A.C., Matthews D.B., Devaud L.L., and Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 139 (1998) 2-19
20. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 129 (1997) 99-111
21. Hines L., Ray L.A., Hutchison K.E., and Tabakoff B. Alcoholism: The dissection for endophenotypes. Dialogues in Clinical Neuroscience 7 (2005) 153-163
22. Hutchison K.E., McGeary J., Smolen A., Bryan A., and Swift R.M. The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychology 21 (2002) 139-146
23. Hutchison K.E., Wooden A., Swift R.M., Smolen A., McGeary J., and Adler L. Olanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 28 (2003) 1882-1888
24. Kaskutas L.A., and Graves K. An alternative to standard drinks as a measure of alcohol consumption. Journal of Substance Abuse 12 (2000) 67-78
25. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: Relevance to addictive drugs. Journal of Neuroscience 22 (2002) 3306-3311
26. King A.C., Volpicelli J.R., Frazer A., and O'Brien C.P. Effects of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 129 (1997) 15-22
27. Kreek M.J. Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochemical Research 21 (1996) 1469-1488
28. Lench N., Stainer P., and Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet 18 (1988) 1356-1358
29. Levenson R.W., Sher K.J., Grossman L.M., Newman J., and Newlin D.B. Alcohol and stress-response dampening: Pharmacological effects, expectancy, and tension reduction. Journal of Abnormal Psychology 89 (1980) 528-538
30. MacKillop J., Menges D.P., McGeary J.E., and Lisman S.A. Effects of craving and DRD4 VNTR genotype of the relative value of alcohol: An initial human laboratory study. Behavioral and Brain Functions 3 (2007). http://www.behavioralandbrainfunctions.com/content/3/1/11 Article 11. Retrieved from http://www.behavioralandbrainfunctions.com/content/3/1/11
31. McCaul M.E., Wand G.S., Stauffer R., Lee S.M., and Rohde C.A. Naltrexone dampens ethanol-induced cardiovascular and hypothalamic-pituitary-adrenal axis activation. Neuropsychopharmacology 25 (2001) 537-547
32. McGeary J.E., Monti P.M., Rohsenow D.J., Tidey J., Swift R., and Miranda Jr. R. Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcoholism: Clinical and Experimental Research 30 (2006) 1288-1296
33. McNair D.M., Lorr M., and Droppleman L.F. Manual for the Profile of Mood States (1971), Educational & Industrial Testing Service, San Diego, CA
34. Miller W.R., Tonigan J.S., and Longabaugh R. The Drinker Inventory of Consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse-Test manual (Project MATCH Monograph Series Vol. 4) (1995), National Institute on Alcohol Abuse and Alcoholism, Rockville, MD
35. National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: A clinician's guide (NIH Publication No. 07-3769) (2005), Author, Bethesda, MD
36. Oak J.N., Oldenhof J., and Van Tol H.H. The dopamine D(4) receptor: One decade of research. European Journal of Pharmacology 405 (2000) 303-327
37. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., and O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28 (2003) 1546-1552
38. Ray L.A., and Hutchison K.E. A polymorphism of the mu-opioid receptor gene and sensitivity to the effects of alcohol in humans. Alcoholism: Clinical and Experimental Research 28 (2004) 1789-1795
39. Ray L.A., and Hutchison K.E. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: A double-blind placebo-controlled study. Archives of General Psychiatry 64 (2007) 1069-1077
40. Robinson T.E., and Berridge K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Review 18 (1993) 247-291
41. Sander T., Harms H., Dufeu P., Kuhn S., Rommelspacher H., and Schmidt L.G. Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics. American Journal of Medical Genetics 74 (1997) 483-487
42. Schuckit M.A., and Smith T.L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry 53 (1996) 202-210
43. Schuckit M.A., and Smith T.L. The relationships of a family history of alcohol dependence, a low level of response to alcohol and six domains of life functioning to the development of alcohol use disorders. Journal of Studies on Alcohol 61 (2000) 827-835
44. Schwartz J.E., and Stone A.A. Strategies for analyzing ecological momentary assessment data. Health Psychology 17 (1998) 6-16
45. Sher K.J., Grekin E.R., and Williams N.A. The development of alcohol use disorders. Annual Review of Clinical Psychology 1 (2005) 493-523
46. Sher K.J., and Levenson R.W. Risk for alcoholism and individual differences in the stress-response dampening of alcohol. Journal of Abnormal Psychology 91 (1982) 350-367
47. Shiffman S., Stone A.A., and Hufford M.R. Ecological momentary assessment. Annual Review of Clinical Psychology 4 (2008) 1-32
48. Sobell L.C., and Sobell M.D. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: Litten R., and Allen J. (Eds). Measuring alcohol consumption (1992), Human Press, Clifton, NJ 41-65
49. Swift R.M., Whelihan W., Kusnetsov O., Buongiorno G., and Hsuing H. Naltrexone-induced alterations in human ethanol intoxication. American Journal of Psychiatry 151 (1994) 1463-1467
50. Tidey J.W., Monti P.M., Rohsenow D.J., Gwaltney C.J., Miranda Jr. R., McGeary J.E., et al. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcoholism: Clinical and Experimental Research 32 (2008) 58-66
51. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Annals of Medicine 35 (2003) 94-121
52. van den Wildenberg E., Janssen R.G., Hutchison K.E., van Breukelen G.J., and Wiers R.W. Polymorphisms of the dopamine D4 receptor gene (DRD4 VNTR) and cannabinoid CB1 receptor gene (CNR1) are not strongly related to cue-reactivity after alcohol exposure. Addiction Biology 12 (2007) 210-220
53. van den Wildenberg E., Wiers R.W., Dessers J., Janssen R.G., Lambrichs E.H., Smeets H.J., and van Breukelen G.J. A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcoholism: Clinical and Experimental Research 31 (2007) 1-10
54. Van Tol H.H., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., et al. Multiple dopamine D4 receptor variants in the human population. Nature 358 (1992, July 9) 149-152
55. Volpicelli J.R., Watson N.T., King A.C., Sherman C.E., and O'Brien C.P. Effects of naltrexone on alcohol "high" in alcoholics. American Journal of Psychiatry 152 (1995) 613-615
56. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Review 94 (1987) 469-492
57. Zeger S.L., Liang K., and Albert P.S. Models for longitudinal data: A generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
58. Zhang Y., Wang D., Johnson A.D., Papp A.C., and Sadee W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by A118G variant. Journal of Biological Chemistry 280 (2005) 32618-32624